• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PULSAR VASCULAR UNKPULSERIDER; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PULSAR VASCULAR UNKPULSERIDER; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Catalog Number UNKPULSERIDER
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Stroke/CVA (1770); Death (1802)
Event Type  Death  
Manufacturer Narrative
Product complaint # (b)(4).Since the product was not returned for analysis, no product failure analysis can be conducted and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the no lot number was provided by the customer.Cerenovus manufacturer's report numbers: 3008680601-2020-00002, 3008680601-2020-00003, 3008680601-2020-00004, 3008680601-2020-00005, 3008680601-2020-00006, 3008680601-2020-00008 are related to the same incident.
 
Event Description
This complaint is from a literature source.As reported in the literature publication entitled, ¿early postmarket results with pulserider for treatment of wide-necked intracranial aneurysms: a multicenter experience¿ (pmid:31703202).1 patient with intracranial aneurysm who was treated with pulserider experienced delayed device thrombosis leading to death.Mechanical thrombectomy was performed, which was technically challenging due to the presence of the pulserider device objective: traditionally, stent-assisted coiling and balloon remodeling have been the primary endovascular treatments for wide-necked intracranial aneurysms with complex morphologies.Pulserider is an aneurysm neck reconstruction device that provides parent vessel protection for aneurysm coiling.The objective of this study was to report early postmarket results with the pulserider device.Methods: this study was a prospective registry of patients treated with pulserider at 13 american neurointerventional centers following fda approval of this device.Data collected included clinical presentation, aneurysm characteristics, treatment details, and perioperative events.Follow-up data included degree of aneurysm occlusion and delayed (> 30 days after the procedure) complications.Cerenovus devices were used in this study.No device specific information (including catalog and lot number) were provided in the article.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKPULSERIDER
Type of Device
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
PULSAR VASCULAR
130 knowles dr suite e
los gatos CA 95032
Manufacturer (Section G)
PULSAR VASCULAR
130 knowles dr suite e
los gatos CA
Manufacturer Contact
gabriel alfageme
31 technology drive
irvine, CA 92618
949789-868
MDR Report Key9666984
MDR Text Key177674749
Report Number3008680601-2020-00007
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
UNK
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 01/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/04/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKPULSERIDER
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/15/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age60 YR
-
-